Scott Fidel
Stock Analyst at Stephens & Co.
(1.77)
# 3,350
Out of 5,127 analysts
185
Total ratings
37.5%
Success rate
-6.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRDN Guardian Pharmacy Services | Maintains: Overweight | $35 → $36 | $34.09 | +5.60% | 2 | Jan 14, 2026 | |
| ARDT Ardent Health | Maintains: Overweight | $21 → $17 | $9.01 | +88.68% | 7 | Nov 14, 2025 | |
| CI The Cigna Group | Maintains: Buy | $370 → $330 | $294.40 | +12.09% | 14 | Nov 4, 2025 | |
| CNC Centene | Maintains: Sell | $33 → $38 | $38.04 | -0.11% | 12 | Oct 31, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $470 → $520 | $497.54 | +4.51% | 11 | Oct 27, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $207 → $167 | $127.53 | +30.95% | 11 | Oct 24, 2025 | |
| UHS Universal Health Services | Assumes: Neutral | $219 | $212.94 | +2.85% | 11 | Oct 14, 2025 | |
| THC Tenet Healthcare | Assumes: Buy | $224 | $192.96 | +16.09% | 11 | Oct 14, 2025 | |
| OSCR Oscar Health | Initiates: Neutral | $17 | $12.66 | +34.28% | 1 | Oct 14, 2025 | |
| ELV Elevance Health | Initiates: Neutral | $343 | $327.50 | +4.73% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $20.76 | +1.16% | 6 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $91 | $75.77 | +20.10% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $406 | $275.70 | +47.26% | 23 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $38 | $30.80 | +23.38% | 18 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $48 → $31 | $38.20 | -18.85% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $143 → $145 | $103.71 | +39.81% | 11 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $199.29 | -16.20% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $189.49 | +31.93% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $106.16 | -1.09% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $13.49 | +581.99% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $7.87 | -80.94% | 3 | Nov 11, 2022 |
Guardian Pharmacy Services
Jan 14, 2026
Maintains: Overweight
Price Target: $35 → $36
Current: $34.09
Upside: +5.60%
Ardent Health
Nov 14, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $9.01
Upside: +88.68%
The Cigna Group
Nov 4, 2025
Maintains: Buy
Price Target: $370 → $330
Current: $294.40
Upside: +12.09%
Centene
Oct 31, 2025
Maintains: Sell
Price Target: $33 → $38
Current: $38.04
Upside: -0.11%
HCA Healthcare
Oct 27, 2025
Maintains: Buy
Price Target: $470 → $520
Current: $497.54
Upside: +4.51%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $207 → $167
Current: $127.53
Upside: +30.95%
Universal Health Services
Oct 14, 2025
Assumes: Neutral
Price Target: $219
Current: $212.94
Upside: +2.85%
Tenet Healthcare
Oct 14, 2025
Assumes: Buy
Price Target: $224
Current: $192.96
Upside: +16.09%
Oscar Health
Oct 14, 2025
Initiates: Neutral
Price Target: $17
Current: $12.66
Upside: +34.28%
Elevance Health
Oct 14, 2025
Initiates: Neutral
Price Target: $343
Current: $327.50
Upside: +4.73%
Oct 14, 2025
Initiates: Buy
Price Target: $21
Current: $20.76
Upside: +1.16%
Oct 14, 2025
Initiates: Buy
Price Target: $91
Current: $75.77
Upside: +20.10%
Oct 14, 2025
Initiates: Buy
Price Target: $406
Current: $275.70
Upside: +47.26%
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $30.80
Upside: +23.38%
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $38.20
Upside: -18.85%
Nov 6, 2024
Maintains: Overweight
Price Target: $143 → $145
Current: $103.71
Upside: +39.81%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $199.29
Upside: -16.20%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $189.49
Upside: +31.93%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $106.16
Upside: -1.09%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $13.49
Upside: +581.99%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $7.87
Upside: -80.94%